CClinicalTrials.gg
CompletedNCT07358494Updated Jan 22, 2026

Effect of Diluted Thyme Honey On Dry Mouth In Intensive Care Unit Patients Exposed to Oxygen Flow Therapy

An interventional study of diluted thyme honey arm and Mouth wash in Nursing Care, sponsored by Esra Yaprak Gokturk. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by Esra Yaprak Gokturk · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Oct 2022, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Sex
All
01

Study summary

This research is a randomized, controlled, double-blind, experimental study conducted to investigate the effect of diluted thyme honey on dry mouth in individuals receiving treatment in intensive care and receiving nasal oxygen flow therapy.

H0: There is no significant difference in reducing dry mouth in intensive care patients receiving nasal oxygen flow therapy between the intervention group receiving oral care with diluted thyme honey and the control group receiving standard oral care.

The study sample consisted of 64 inpatients receiving nasal oxygen flow therapy in the Emergency Intensive Care and Emergency Critical Intensive Care Units of Ankara Training and Research Hospital. Patients were divided into groups using a sealed envelope method. Patients in the intervention group received oral care using diluted thyme honey, while patients in the control group received oral care using 0.9% NaCl.

Read the detailed description

SUMMARY

Backround Dry mouth due to nasal oxygen flow therapy is one of the side effects frequently experienced by patients treated in intensive care units. Although there are various pharmacological and complementary medicine methods for the prevention and treatment of dry mouth, this condition continues to negatively affect the daily lives of patients due to the lack of a definitive method and the neglect of oral care.

Aim The aim of this study was to evaluate the efficacy of diluted thyme honey in preventing dry mouth in intensive care patients receiving nasal oxygen flow therapy.

Desing This study has a randomized controlled experimental design.

Methods This study included 64 intensive care unit patients receiving nasal oxygen flow therapy. It was a randomized controlled experimental study consisting of intervention (thyme honey) and control group (0.9% NaCl). Participants were randomized to the groups by closed envelope method. 32 patients were included in both groups. Patients in both groups included in the study underwent the same protocol steps except for the oral care product (thyme honey and 0.9% NaCl). After obtaining consent from the patients who agreed to be included in the study, information about the participants was collected by asking the Patient Information Form prepared by the researcher. The Subjective Dry Mouth Form was administered to the participants before the start of the study and at the end of the 3rd day when the application protocols were completed. After the applications were completed, the pre-test and post-test scores of the patients in response to each question in the 'Subjective Dry Mouth Evaluation Form' and their answers to an open-ended question about their opinions on thyme honey in the Patient Information Form were combined in the patient follow-up form.

02

Conditions studied

  • Nursing Care

Browse trials for

Keywords

  • Xerostomia
  • Thyme Honey
  • Nursing
  • Nasal Oxygen Flow Treatment
03

In context

Xerostomia

254 studies on the registry are indexed under Xerostomia; 47 are open to participants now.

This study's enrollment of 64 is above the median of 42 across 216 interventional studies indexed under Xerostomia.

Browse Xerostomia studies →

Lead sponsor

This is the only study on the registry with Esra Yaprak Gokturk as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being treated under intensive care conditions and receiving nasal oxygen flow therapy above 4L/min,
  • Over 18 years of age,
  • Not diagnosed with Sjögren's Syndrome,
  • No previous exposure to radiotherapy or chemotherapy,
  • Has not had a salivary gland infection,
  • Has not undergone an operation to remove the salivary glands,
  • Not allergic to honey,
  • No chewing or swallowing difficulties,
  • Not using thyme-containing products for oral care in the previous period,
  • Patients who did not have any communication problems and who voluntarily agreed to participate in the study were included in the study

Exclusion criteria

Exclusion Criteria:

- Patients who did not meet the inclusion criteria and did not voluntarily agree to participate in the study were excluded.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    diluted thyme honey arm

    * After obtaining informed consent from participants who agreed to participate in the study, they were asked to draw one sealed envelope from a bag containing sealed envelopes numbered from 1 to 64. The envelopes drawn by the patients were opened in their presence. The researcher determined whether the patients would be included in the intervention or control group based on the number drawn from the envelope. * Participants assigned to the intervention group were first given the Patient Information Form. Then, before starting the intervention, participants were asked questions from the "Subjective Dry Mouth Assessment Form" prepared by Duruk (2012) using the Visual Analogue Scale. Each point given in response to the questions was recorded in the Patient Follow-up Form. * Patients were educated on the importance of dry mouth, the types of foods and liquids to avoid, the necessity of adequate saliva secretion, the functions of saliva, methods of coping with dry mouth, and the necess

    Other: diluted thyme honey arm · Other: Mouth wash

  • Placebo comparator
    0.9% NaCl arm

    After obtaining informed consent from participants who agreed to participate in the study, they were asked to draw one sealed envelope from a bag containing sealed envelopes with numbers ranging from 1 to 64 written on them. The envelopes drawn by the patients were opened in their presence. Patients were assigned to either the intervention or control group according to the number drawn from the envelope. * Participants in the control group were first given the Patient Information Form. Then, before starting the application, they were asked questions from the Subjective Dry Mouth Assessment Form. Each point given in response to the questions was recorded in the Patient Follow-up Form. * Patients were educated on the importance of dry mouth, the types of foods and liquids to avoid, the necessity of adequate saliva secretion, the functions of saliva, methods for coping with dry mouth, and the necessary precautions to identify and report any side effects that

    Other: Mouth wash

Interventions

  • Otherdiluted thyme honey arm

    In this study, the feasibility of an alternative method for alleviating dry mouth, which is very important in terms of nursing care, was investigated. The effect of diluted thyme honey, which had not been previously studied, on dry mouth was investigated in intensive care patients receiving nasal oxygen flow therapy in the intervention group. The control group received oral care using a standard oral care solution of 0.9% NaCl.

  • OtherMouth wash

    In this study, the usability of an alternative method for the elimination of dry mouth, which has a very important place in terms of nursing care, was investigated. The effect of diluted thyme honey on dry mouth in intensive care patients receiving nasal oxygen flow therapy, which has not been previously studied in the literature, was investigated.

06

What researchers measure

Primary outcomes

  1. The Effect of Diluted Thyme Honey on Dry Mouth in Intensive Care Patients Receiving Nasal Oxygen Flow Therapy: A Randomized Controlled Trial

    The Subjective Dry Mouth Assessment Form was used to assess dry mouth. This form includes questions regarding symptoms such as "dry mouth," "difficulty swallowing," "difficulty speaking," "waking up from sleep," "dry tongue," "burning mouth," "burning throat," "dry throat," "thirst," "bad taste in the mouth," "saliva volume," and "bad breath." Responses are scored on a 0-10 scale using 11 Visual Analogue Scales (VAS). Scoring begins with 0 (not at all) and ends with 10 (extremely). The Subjective Dry Mouth Assessment Form was administered to patients before the study began to gather patient information and determine their dry mouth levels. At the end of the third day, the Subjective Dry Mouth Assessment Form was administered to the patients, who underwent three days of treatment, and their dry mouth was re-evaluated. Data on the patients' dry mouth levels were collected before and after the study.

    Time frame: 9 week

07

Study locations

1 site
  • Ankara University Institute of Health Sciences Department of Nursing
    Ankara, Dışkapı 6070, Turkey (Türkiye)
08

References and documents

Publications

  • YAVUZ KARAMANOĞLU A, YAVUZ M (2015). Ağız Sağlığı Hemşirelik Değerlendirmesinde Kanıtlar Ve Uygulama Önerileri. Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 31(1): 131-143.
  • Takzaree N, Hassanzadeh G, Rouini MR, Manayi A, Hadjiakhondi A, Majidi Zolbin M. Evaluation of the Effects of Local Application of Thyme Honey in Open Cutaneous Wound Healing. Iran J Public Health. 2017 Apr;46(4):545-551. PubMed 28540272 ↗
  • TABACHNICK B G, FIDELL L S, (2013). Using multivariate statistics. Boston:Pearson. 6: 497-516.
  • SEO E, SONG J, HUR M, LEE M, SOO LEE M (2017). Effects of aroma mouthwash on stress level, xerostomia, and halitosis in healthy nurses: A non-randomized controlled clinical trial. European Journal of Integrative Medicine, 10: 82-89. DOI: 10.1016/j.eujim.2017.03.001
  • ÖZKÖK A, KORU Ö, SORKUN K (2016). Microbiological Analysis And Antibacterial Effects Of Turkish Thyme Honey. Bee World, 93(4): 98-101. DOI: 10.1080/0005772X.2016.1275489
  • Lopez-Pintor RM, Casanas E, Gonzalez-Serrano J, Serrano J, Ramirez L, de Arriba L, Hernandez G. Xerostomia, Hyposalivation, and Salivary Flow in Diabetes Patients. J Diabetes Res. 2016;2016:4372852. doi: 10.1155/2016/4372852. Epub 2016 Jul 10. PubMed 27478847 ↗
  • Li Y, Taylor JM, Ten Haken RK, Eisbruch A. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):660-9. doi: 10.1016/j.ijrobp.2006.09.021. Epub 2006 Dec 4. PubMed 17141973 ↗
  • Lagerlof F, Dawes C. The volume of saliva in the mouth before and after swallowing. J Dent Res. 1984 May;63(5):618-21. doi: 10.1177/00220345840630050201. PubMed 6584462 ↗
  • Lafraxo H, Bakour M, Laaroussi H, El Ghouizi A, Ousaaid D, Aboulghazi A, Lyoussi B. The Synergistic Beneficial Effect of Thyme Honey and Olive Oil against Diabetes and Its Complications Induced by Alloxan in Wistar Rats. Evid Based Complement Alternat Med. 2021 Sep 20;2021:9949056. doi: 10.1155/2021/9949056. eCollection 2021. PubMed 34594393 ↗
  • Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1187-94. doi: 10.1016/j.ijrobp.2004.12.051. PubMed 15990024 ↗
  • Kobya Bulut H, Guducu Tufekci F. Honey prevents oral mocositis in children undergoing chemotherapy: A quasi-experimental study with a control group. Complement Ther Med. 2016 Dec;29:132-140. doi: 10.1016/j.ctim.2016.09.018. Epub 2016 Sep 19. PubMed 27912937 ↗
  • KILAVUZ, DERVİŞ KAAN (2014). Türk Toplumunda Ağız Kuruluğu Prevalansının Araştırılması. Doktora Tezi, Gazi Üniversitesi.
  • Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007 Dec;20(6):719-25. doi: 10.1097/WCO.0b013e3282f1a06e. PubMed 17992096 ↗
  • Hashemian F, Baghbanian N, Majd Z, Rouini MR, Jahanshahi J, Hashemian F. The effect of thyme honey nasal spray on chronic rhinosinusitis: a double-blind randomized controlled clinical trial. Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1429-35. doi: 10.1007/s00405-014-3233-x. Epub 2014 Aug 9. PubMed 25106547 ↗
  • Hanchanale S, Adkinson L, Daniel S, Fleming M, Oxberry SG. Systematic literature review: xerostomia in advanced cancer patients. Support Care Cancer. 2015 Mar;23(3):881-8. doi: 10.1007/s00520-014-2477-8. Epub 2014 Oct 18. PubMed 25322971 ↗
  • GEORGE D, MALLERY M (2010). SPSS for Windows Step by Step: A Simple Guide and Reference, 17.0 update (10a ed.) Boston: Pearson
  • Ganjre A, Kathariya R, Bagul N, Pawar V. Anti-carcinogenic and Anti-bacterial Properties of Selected Spices: Implications in Oral Health. Clin Nutr Res. 2015 Oct;4(4):209-15. doi: 10.7762/cnr.2015.4.4.209. Epub 2015 Oct 31. PubMed 26566515 ↗
  • Fantozzi PJ, Pampena E, Di Vanna D, Pellegrino E, Corbi D, Mammucari S, Alessi F, Pampena R, Bertazzoni G, Minisola S, Mastroianni CM, Polimeni A, Romeo U, Villa A. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. Am J Otolaryngol. 2020 Nov-Dec;41(6):102721. doi: 10.1016/j.amjoto.2020.102721. Epub 2020 Sep 10. PubMed 32977063 ↗
  • DURUK NAZİKE (2012). Hemodiyaliz Sırasında Ciklet Çiğnemenin Ağız Kuruluğu Ve Semptomlarına Etkisi. Doktora Tezi, Ege Üniversitesi.
  • DAVIES A N. EPSTEIN J B (2010). Salivary gland dysfunction Oral Complications of Cancer and its Management. Oxford University Press, p: 203-223. DOI: 10.1016/j.gerinurse.2015.10.014
  • Dalodom S, Lam-Ubol A, Jeanmaneechotechai S, Takamfoo L, Intachai W, Duangchada K, Hongsachum B, Kanjanatiwat P, Vacharotayangul P, Trachootham D. Influence of oral moisturizing jelly as a saliva substitute for the relief of xerostomia in elderly patients with hypertension and diabetes mellitus. Geriatr Nurs. 2016 Mar-Apr;37(2):101-9. doi: 10.1016/j.gerinurse.2015.10.014. Epub 2015 Nov 26. PubMed 26631691 ↗
  • Crogan NL. Managing xerostomia in nursing homes: pilot testing of the Sorbet Increases Salivation intervention. J Am Med Dir Assoc. 2011 Mar;12(3):212-6. doi: 10.1016/j.jamda.2010.06.002. Epub 2010 Oct 8. PubMed 21333924 ↗
  • Chanques G, Constantin JM, Sauter M, Jung B, Sebbane M, Verzilli D, Lefrant JY, Jaber S. Discomfort associated with underhumidified high-flow oxygen therapy in critically ill patients. Intensive Care Med. 2009 Jun;35(6):996-1003. doi: 10.1007/s00134-009-1456-x. Epub 2009 Mar 18. PubMed 19294365 ↗
  • Charalambous M, Raftopoulos V, Paikousis L, Katodritis N, Lambrinou E, Vomvas D, Georgiou M, Charalambous A. The effect of the use of thyme honey in minimizing radiation - induced oral mucositis in head and neck cancer patients: A randomized controlled trial. Eur J Oncol Nurs. 2018 Jun;34:89-97. doi: 10.1016/j.ejon.2018.04.003. Epub 2018 Apr 30. PubMed 29784145 ↗
  • Charalambous A, Lambrinou E, Katodritis N, Vomvas D, Raftopoulos V, Georgiou M, Paikousis L, Charalambous M. The effectiveness of thyme honey for the management of treatment-induced xerostomia in head and neck cancer patients: A feasibility randomized control trial. Eur J Oncol Nurs. 2017 Apr;27:1-8. doi: 10.1016/j.ejon.2017.01.001. Epub 2017 Jan 16. PubMed 28279391 ↗
  • BORAHAN, M.OĞUZ (2005). Anksiyete, Depresyon, Stres ve Medikasyonun Tükürük Akış Hızı ve Subjektif Ağız Kuruluğu Üzerine Olan Etkilerinin İncelenmesi. Doktora Tezi, Marmara Üniversitesi.
  • BİLGE M, TOZOĞLU Ü, 2022. Diyabetes Mellitus Olgularında Oral Mukoza Bulguları. Duzce Medical Journal, 12(2): 12 - 16.
  • BİÇİCİ, BERNA (2010). Mcgill Ağrı Ölçeği Kısa Formu"nun Geçerlik Ve Güvenirliğinin İncelenmesi. Yüksek Lisans Tezi, Ege Üniversitesi.
  • BENLİ M, YİĞİT KAYHAN N (2005). Ülkemizde Yaygın Kullanımı Olan Kekik (Thymus Vulgaris) Bitkisinin Antimikrobiyal Aktivitesi. Orlab On-Line Mikrobiyoloji Dergisi , 3(8) 1-8.
  • Bardy J, Molassiotis A, Ryder WD, Mais K, Sykes A, Yap B, Lee L, Kaczmarski E, Slevin N. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Br J Oral Maxillofac Surg. 2012 Apr;50(3):221-6. doi: 10.1016/j.bjoms.2011.03.005. Epub 2011 Jun 1. PubMed 21636188 ↗
  • Bardy J, Slevin NJ, Mais KL, Molassiotis A. A systematic review of honey uses and its potential value within oncology care. J Clin Nurs. 2008 Oct;17(19):2604-23. doi: 10.1111/j.1365-2702.2008.02304.x. PubMed 18808626 ↗
  • ATASOY, BESTE MELEK (2002). Radyoterapi Gören Baş Boyun Tümörlü Hastalarda Oluşan Akut ve Konik Kserostominin Amifostin ile Azaltılabilirliğinin İncelenmesi. Uzmanlık Tezi, Marmara Üniversitesi.
  • ARSLANTAŞ TAMARA (2009). Kserostomi Oluşturulan Rat Modelinde Gastrik Reflünün Östaki Tüp Fonksiyonları Üzerine Olan Olumsuz Etkilerine Karşı Tükürüğün Koruyucu Etkileri. Uzmanlık Tezi, Süleyman Demirel Üniversitesi.
  • Anggraeni DT, Hayati AT, Nur'aeni A. The effect of oral care using honey as an additional topical agent on oral health status of intubated patients in the intensive care unit. Enferm Intensiva (Engl Ed). 2022 Oct-Dec;33(4):225-232. doi: 10.1016/j.enfie.2021.12.004. PubMed 36494157 ↗
  • Bahramnezhad F, Dehghan Nayeri N, Bassampour SS, Khajeh M, Asgari P. Honey and Radiation-Induced Stomatitis in Patients With Head and Neck Cancer. Iran Red Crescent Med J. 2015 Oct 22;17(10):e19256. doi: 10.5812/ircmj.19256. eCollection 2015 Oct. PubMed 26568850 ↗

Study documents

  • Study protocol · Nov 30, 2022
  • Statistical analysis plan · Nov 30, 2022
  • Informed consent form · Nov 30, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07358494
Lead sponsor
Esra Yaprak Gokturk
Responsible party
Esra Yaprak Gokturk (MSN: Master of Science in Nursing, Ankara University) — Sponsor-investigator
First posted
Jan 22, 2026
Start date
Oct 1, 2022
Primary completion
Nov 30, 2022
Completion
Nov 30, 2022
Last update
Jan 22, 2026

Study contacts

ayten demir, assoc.prof.dr.
study director · Ankara University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion